IP Library Granted Patent US 7,476,548
Granted Patent B2
US 7,476,548 · App. 10/816,230 · Granted Jan 13, 2009

Dry reagent strip configuration, composition and method for multiple analyte determination

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,476,548
App. No.
10/816,230
Granted
Jan 13, 2009
Kind
B2
Abstract

An assay device, analytical instrument and assay method for determining the presence or amount of an analyte in a fluid is disclosed. The device is a one-step lateral flow dry reagent immunoassay with one, two or more zones along a transverse axis of the device, each zone can contain or be preceded by diffusively or non-diffusively bound reagents. The invention measures an indicator in one or two test zones for each analyte to determine its presence or concentration. The signal reagent (indicator) may be a particle such as a colored latex or colloidal gold. The assay quantitation may be read by an instrument.

Claims (36)

1. A dry reagent lateral flow strip assay device for detecting two or more analytes in a test sample comprising:

a) a sample application zone; and

b) two or more test zones;

wherein the sample application zone and the two or more test zones are in fluid communication with one another through a transport matrix; and wherein the transport matrix further comprises a lateral path along which the sample travels in a lateral direction, and a transverse path along which the sample travels in a direction transverse to said lateral path, said lateral path being in a two-dimensional plane and said transverse path being in a third dimensional plane so as to direct said test sample to said two or more test zones.

2. The assay device of claim 1 for performing general chemistry assays, wherein the two or more test zones are general chemistry reagent zones comprising at least one enzyme.

3. The assay device of claim 2 , wherein the enzyme produces a reaction product when at least one of the analytes is present in the sample.

4. The assay device of claim 1 , wherein the two or more analytes are general chemistry analytes selected from the group consisting of: creatine, creatinine, glucose, cholesterol, high density lipoprotein (HDL) cholesterol, N-telopeptide, low density lipoprotein (LDL) cholesterol, triglycerides and blood urea nitrogen (BUN).

5. The assay device of claim 1 , wherein one of the at least two or more test zones is a general chemistry reagent zone, said general chemistry reagent zone further comprising an indicator.

6. The assay device of claim 5 , wherein the indicator forms a detectable signal when at least one of the analytes is present in the sample.

7. The assay device of claim 1 for performing a binding assay, wherein the two or more test zones are binding member zones comprising at least one binding member.

8. The assay device of claim 7 , wherein the binding member is an antibody.

9. The assay device of claim 8 , wherein the antibody is immobilized in the binding member zone.

10. The assay device of claim 9 , wherein the antibody is diffusively immobilized in the binding member zone.

11. The assay device of claim 9 , wherein the antibody is non-diffusively immobilized in the binding member zone.

12. The assay device of claim 7 , wherein at least one of the binding members forms a complex with at least one analyte.

13. The assay device of claim 7 , wherein at least one of the binding member zones further comprises an indicator that forms a detectable signal when at least one of the analytes is present in the sample.

14. The assay device of claim 1 , wherein the two or more analytes are selected from the group consisting of: antigens, antibodies, macromolecules, vitamins, lectins, carbohydrates, proteins, peptides, amino acids, hormones, steroids, therapeutic drugs, drugs of abuse, bacterium and viruses.

15. The assay device of claim 1 , wherein the two or more analytes are haptens that form binding pairs with antibodies.

16. The assay device of claim 1 , wherein the sample application zone further comprises a sample pad in fluid communication with the transport matrix.

17. The assay device of claim 16 , further comprising a sample treatment pad in fluid communication with the transport matrix.

18. The assay device of claim 17 , wherein the sample treatment pad comprises a quarternary ammonium derived membrane for trapping ascorbate and other anionic interferents.

19. The assay device of claim 16 , further comprising a sample filter pad in fluid communication with the transport matrix for removing undesired contaminants from the sample.

20. The assay device of claim 16 , wherein the sample pad removes large particulate debris from the sample.

21. The assay device of claim 16 , wherein the sample pad adjusts the pH and ionic composition of the sample.

22. The assay device of claim 1 , wherein the transport matrix is a porous material along which the sample travels laterally.

23. The assay device of claim 1 , further comprising a metering layer between the transport matrix and the two or more test zones through which the sample spreads uniformly across the transport matrix.

24. The assay device of claim 1 , further comprising a detection zone corresponding to each test zone.

25. The assay device of claim 1 , further comprising a sample treatment pad overlapping said transport matrix, a first layer also overlapping said transport matrix, and a second layer overlapping said first layer.

26. The assay device of claim 25 , wherein said two or more test zones are located in said second layer.

27. A dry reagent lateral flow strip assay device for detecting two or more analytes in a test sample comprising:

a) a sample application zone; and

b) two or more test zones;

wherein the sample application zone and the two or more test zones are in fluid communication with one another through a transport matrix;

wherein said sample application zone further includes a sample pad and a sample treatment pad in fluid communication with said transport matrix;

wherein said sample treatment pad comprises a quaternary ammonium derived membrane for trapping ascorbate and other anionic interferents; and

wherein the transport matrix further comprises a lateral path along which the sample travels laterally, and a transverse path along which the sample travels transversely.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 26, 2023
From: PNC BANK, NATIONAL ASSOCIATION ,AS AGENT
To: POLYMER TECHNOLOGY SYSTEMS,INC.
Reel/Frame 062496/0384 →
SECURITY INTEREST Recorded Jun 4, 2014
From: POLYMER TECHNOLOGY SYSTEMS, INC.
To: PNC BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 033083/0614 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2014
From: PTS ACQUISITION CORPORATION
To: POLYMER TECHNOLOGY SYSTEMS, INC.
Reel/Frame 032173/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2014
From: BAYER HEALTHCARE, LLC
To: PTS ACQUISITION CORPORATION
Reel/Frame 032173/0050 →
SECURITY AGREEMENT Recorded Feb 6, 2014
From: POLYMER TECHNOLOGY SYSTEMS, INC.
To: PNC BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 032166/0875 →
MERGER Recorded May 16, 2008
From: METRIKA, INC.
To: BAYER HEALTHCARE LLC
Reel/Frame 020986/0686 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2004
From: BLATT, JOEL M.; MANGAN, WILMA M.
To: METRIKA INC.
Reel/Frame 015252/0418 →